Fractionated marine invertebrate extract libraries for drug discovery.
about
Lessons from the past and charting the future of marine natural products drug discovery and chemical biologyModern natural products drug discovery and its relevance to biodiversity conservationCarteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp.Making the most of Papua New Guinea's biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in "The Land of the Unexpected"Automated high-throughput system to fractionate plant natural products for drug discovery.Natural Products as a Foundation for Drug Discovery.Evaluation of pyridoacridine alkaloids in a zebrafish phenotypic assay.Mass spectrometry of natural products: current, emerging and future technologiesInteractions of Papua New Guinea medicinal plant extracts with antiretroviral therapyConcepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays.Identification of a molecular target of a novel fungal metabolite, pyrrolizilactone, by phenotypic profiling systems.Comparative study of chromatographic medium-associated mass and potential antitumor activity loss with bioactive extracts.Matching the power of high throughput screening to the chemical diversity of natural productsFast Screening of Antibacterial Compounds from Fusaria.Bioactive Potential of Marine Macroalgae from the Central Red Sea (Saudi Arabia) Assessed by High-Throughput Imaging-Based Phenotypic Profiling.Assessing pressurized liquid extraction for the high-throughput extraction of marine-sponge-derived natural products.Development and Application of a Novel SPE-Method for Bioassay-Guided Fractionation of Marine Extracts.Isolation of pyrrolocins A-C: cis- and trans-decalin tetramic acid antibiotics from an endophytic fungal-derived pathway.4-Quinolone alkaloids from Melochia odorata.
P2860
Q26863108-991A2638-FEC9-4495-A0CB-BD2D4C4E8620Q29353836-04394851-B1C1-4800-8D95-41B6B2534B07Q33506487-B63CE4CD-3F7E-43D0-B080-E432EB3A2678Q33519039-69D9B87C-DF55-46BB-B4DC-978C8175ADC8Q33541158-DBE0270A-42CC-494B-8787-569CC7D07B11Q33617301-DF015CFD-F898-4543-8B3E-E8A315398956Q33983791-347EF42C-3477-4018-B6A3-C1E64F7E3231Q34165224-C5E0FDF1-9D29-4CAA-8CA2-AB942E2882BDQ34587582-8B975D8B-C71F-4294-8965-C74E1664936BQ34608038-7A2B2A7C-9001-4281-AFC0-45C6812356D9Q35027521-6D093AA6-A4B4-4B87-91B9-3E651F701507Q36931194-393938F8-5060-44A0-BC54-B6CC1C2E2E21Q37240957-3263002B-B66E-4701-954E-3F49C0D68112Q37543586-E5D76BB9-2524-4C8B-A116-32E7A42F9940Q37721836-4A965D1C-6F72-4F35-AD98-2EF280F5EA5BQ39817269-55F3436C-DC6B-422F-B618-AAC4DF8D1B1FQ40530861-7AB316A3-D810-4762-8B14-0F9B7B00DB24Q41774077-BB56DAEC-E1EA-4B86-88EC-A8C0F3B213A6Q41970206-59009D55-13C6-4889-A0DD-45AF7652FC3E
P2860
Fractionated marine invertebrate extract libraries for drug discovery.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fractionated marine invertebrate extract libraries for drug discovery.
@ast
Fractionated marine invertebrate extract libraries for drug discovery.
@en
type
label
Fractionated marine invertebrate extract libraries for drug discovery.
@ast
Fractionated marine invertebrate extract libraries for drug discovery.
@en
prefLabel
Fractionated marine invertebrate extract libraries for drug discovery.
@ast
Fractionated marine invertebrate extract libraries for drug discovery.
@en
P2093
P2860
P1433
P1476
Fractionated marine invertebrate extract libraries for drug discovery.
@en
P2093
Chris M Ireland
Jason Reppart
Malcolm W B McCulloch
Mary Kay Harper
Tim S Bugni
P2860
P304
P356
10.3390/MOLECULES13061372
P407
P577
2008-06-19T00:00:00Z